1. Home
  2. OMH vs MDCX Comparison

OMH vs MDCX Comparison

Compare OMH & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$1.37

Market Cap

28.7M

Sector

Finance

ML Signal

N/A

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.50

Market Cap

26.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
MDCX
Founded
2015
2008
Country
Singapore
United States
Employees
N/A
12
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
26.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
OMH
MDCX
Price
$1.37
$0.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
25.5K
8.6M
Earning Date
11-28-2025
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.37
52 Week High
$4.33
$8.90

Technical Indicators

Market Signals
Indicator
OMH
MDCX
Relative Strength Index (RSI) 52.67 32.02
Support Level $1.03 $0.37
Resistance Level $1.35 $1.43
Average True Range (ATR) 0.09 0.12
MACD 0.02 -0.01
Stochastic Oscillator 75.61 11.01

Price Performance

Historical Comparison
OMH
MDCX

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Share on Social Networks: